top of page

Peer Reviewed Conference Papers

download_edited.jpg

The RNA Splicing Factor U2AF1 Controls Hematopoietic Stem Cell Survival and Function

American Society of Hematology (ASH) Annual Meeting 2020

https://ashpublications.org/blood/article/136/Supplement%201/9/470702/The-RNA-Splicing-Factor-U2AF1-Controls

​

41388_2016_Article_BFonc2015407_Fig3_HTML.jpeg

The CDK6 Inhibitor Palbociclib in Combination with Ruxolitinib Remarkably Improves Myelofibrosis in Murine Models

ASH Annual Meeting 2019

https://ashpublications.org/blood/article/134/Supplement_1/4200/425621/The-CDK6-Inhibitor-Palbociclib-in-Combination-with

​

cancers-12-02216-g001-550_edited.png

Critical Requirement of U2AF1 in the Maintenance and Function of Hematopoietic Stem Cells

ASH Annual Meeting 2019

https://ashpublications.org/blood/article/134/Supplement_1/1195/426649/Critical-Requirement-of-U2AF1-in-the-Maintenance

​

download (1).png

The NF-KB Inhibitor DMAPT in Combination with Ruxolitinib Displays Efficacy in Jak2V617F Knock-in Mouse Model of Myeloproliferative Neoplasms

ASH Annual Meeting 2018

https://doi.org/10.1182/blood-2018-99-120195

​

br-04-02-0140-g00.jpeg

The PIM Kinase Inhibitor TP-3654 in Combination with Ruxolitinib Exhibits Marked Improvement of Myelofibrosis in Murine Models

ASH Annual Meeting 2018

https://doi.org/10.1182/blood-2018-99-119421

​

29571.png

The PIM kinase inhibitor TP-3654 demonstrates efficacy in a murine model of myelofibrosis

American Association for Cancer Research (AACR) Annual Meeting 2018

https://cancerres.aacrjournals.org/content/78/13_Supplement/1874

​

images.png

Expression of HMGA2 Cooperates with Jak2V617F in the Development of Myelofibrosis

ASH Annual Meeting 2016

https://doi.org/10.1182/blood.V128.22.797.797

​

Conference Papers : Projects
bottom of page